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The purpose of this study was to assess characteristics, 
treatment outcomes and complications in patients with 
locally advanced or recurrent gynecological malignancies 
treated with interstitial brachytherapy using MUPIT. 
Materials and Methods: We performed a retrospective 
review of all patients with gynecological malignancies 
treated with MUPIT in a single institution between January 
2005 and May 2014. Cases without data or follow up were 
excluded. Information recorded were demographic and clinic 
characteristics, previous use of RT (external or BT), dose rate 
of interstitial BT, local control rate, late toxicity and 
mortality rate. Categorical variables are presented as 
frequencies and proportions, and continuous variables as the 
mean, median, and range. Local recurrence-free survival 
(LRFS) and overall survival (OS) after MUPIT treatment were 
estimated using the Kaplan-Meier method. 
Results: Forty six patients were identified. The median age 
was 64 years (range, 28 - 85). Cervical and endometrial 
cancers were the most common primary site, with 20 and 16 
cases respectively. The indications of interstitial BT were 
treatment of local recurrence (31), primary tumor (14) and 
metastases (1). Forty patients received external RT or BT 
before interstitial BT. High dose rate BT was used in 37 cases. 
Median LRFS was 76.2 months (CI 95% 61.6 - 90.7) and the 
median survival time was 82 months (CI 95% 67.5 - 96.5). 
There have been no cases of Grade IV late toxicity. Proctitis 
and pelvic pain were the most common grade III 
complications (4 patients). 
Conclusions: Interstitial BT using MUPIT applicator is an 
effective treatment which obtains high rates of local control 
despite the bad prognosis of pelvic recurrencies. Secondary 
effects are few, and manageable. 
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Purpose/Objective: Bone marrow sparing using intensity-
modulated radiotherapy (IMRT) could reduce haematological 
toxicity from radical chemoradiation for cervical carcinoma. 
One challenge is to determine the location of functioning 
bone marrow rather than attempt to spare the whole bony 
pelvis. On FDG-PET the areas of higher activity correlate with 
SUV values, and the scans used to stage disease could 
potentially be used to also identify functioning bone marrow. 
The aims of this study were to identify functioning pelvic 
bone marrow using FDG-PET, to analyse the pattern of 
distribution between patients and to develop guidelines for 
defining bone marrow as an organ at risk which can be 
applied to radiotherapy CT scans for all patients.  
Materials and Methods: The FDG-PET scans from 10 patients 
treated for cervical cancer were assessed. Structure sets 
consisting 6 absolute SUV thresholds (0.5,1.0, 1.5, 2.0, 2.5 
and 3.0) were created. The distribution of SUV activity within 
each pelvic subregion and the whole bony pelvis was 
analysed. The maximum SUV value within the bony pelvis 
(SUVmax) was defined as the highest level with a volume > 
1cc. Volumetric data for SUVMax, SUV >75%Max (SUV75) and 
SUV>50%Max (SUV50) were compared, measuring the 
contribution to each region and to the total activity.  
Results: The absolute SUV values within the pelvis varied 
between patients whereas relative values were more 
comparable. A reproducible pattern of distribution was 
evident in all patients using SUV75. The highest activity is 
seen within the lumbar spine, sacrum, posterior iliac alae and 
pubic bone contributing 86.67% total activity. For SUV75, the 
SUV range was 1.0 – 2.5 with a mean volume of 98.9cc (Range 
19.99 – 196.0cc, SD 50.3), which is 6.9% (range 1.7 – 12.9, SD 
3.2) of the mean total pelvic volume. 
Conclusions: There is a reproducible pattern of functional 
bone marrow on FDG-PET within the pelvis. Guidelines for 
contouring a standard avoidance structure on the planning CT 
scan have been generated which encompass the areas of 
highest activity. Bone marrow avoidance should be assessed 
further in dosimetric and clinical studies. 
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Purpose/Objective: To monitor changes in tumour 
microenvironment including hypoxia of cervix cancer patients 
undergoing chemoradiation with positron emission 
tomography and multiparametric 3T-magnetic resonance 
imaging (MP-PET/MRI) using T2-weighted, T1-weighted, 
dynamic-contrast-enhanced (DCE) MRI, diffusion-weighted 
imaging (DWI) and 18F-fluoromisonidazole 
(18F-FMISO). 
Materials and Methods: Seven patients underwent 18F-FMISO-
PET/CT and MP-MRI at baseline; 2 and 5 weeks(w) after 
treatment start and 3 months after treatment end. Data were 
registered, fused and analyzed using Mirada RTx software 
(Mirada Medical Ltd, Oxford,UK). Gross tumour volume (GTV) 
was contoured by an experienced radiation oncologist on 
PET/MRI data sets. The volume of GTV was analysed for size, 
EH-kinetics, diffusivity and 18F-FMISO-avidity using SUVmax 
and SUV-normalized to gluteal muscle uptake. At follow up, 
cervix was contoured, since all patients showed clinically 
complete remission. 
Results: Median GTV volume was 43.9cc at baseline, 22.4cc 
after 2w (20-25Gy) and 7.7cc after 5w (40-45Gy). Mean ADC 
values were 1.02x10-3mm2/sec increasing to 1.18x10-
3mm2/sec after 2w and to 1.27x10-3mm2/sec after 5w and 
were 1.37x10-3mm2/sec at 3 months. All GTVs showed mean 
initial-enhancement (IE) followed by a plateau with an 
increasing IE at 2w and 5w and wash-out at 5w. At follow-up, 
the mean IE was 120% followed by a persistent enhancement. 
The mean 18F-FMISO SUV-norm was 3.1 at baseline and 
decreased to 2.3 at 2w and 2.0 at 5w and follow-up. 
Conclusions: There are morphological and functional changes 
in tumor diffusion, perfusion and hypoxia during treatment 
which can be non-invasively monitored with MP-MRI/PET. The 
